Expansion Gaps Despite boasting +30 locations across North America, Field Trip Health (Stella) has recently closed several clinics including Chicago, Seattle, San Diego, Washington DC, Fredericton, and others. This presents an opportunity to re-engage shuttered or underperforming markets with refreshed offerings, hybrid care models, or targeted partnerships to reclaim footprint and broaden geographic reach.

Hybrid Care Growth The company has progressed from in-person psychedelic therapies to a hybrid model combining app-based guidance and telehealth ketamine therapy. There is potential to upsell or cross-sell digital mental health solutions, remote monitoring, and companion apps to clinics or enterprise customers seeking scalable, tech-enabled care.

Financial Scale With funding of 112 million and revenue in the low single-digit millions, there is a clear path for capital-efficient partnerships or services that optimize clinic operations, reduce cost per patient, or accelerate clinical trials and regulatory pathways—areas where technology providers, EHR integrations, and analytics firms can deliver value.

Clinical Trial Synergy Active clinical trials and a focus on biological treatments create a demand for research management tools, data analytics, patient recruitment platforms, and trial patient engagement solutions that can streamline study operations for Stella and potential CRO partners.

Tech Stack Fit Current tech stack includes Google Workspace, Jira, React, and Nginx, indicating openness to modern collaboration, productization, and integration opportunities. Partners offering cloud collaboration enhancements, secure telehealth platforms, or integrative dashboards could improve clinical workflows and patient experience.